(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.
The three biggest winners today are FuboTV, Zscaler, and Republic First Bancorp.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | FuboTV (FUBO) | 1.85 | 25.85% | 2023-05-08 13:47:13 |
| 2 | Zscaler (ZS) | 107.45 | 20.11% | 2023-05-08 14:48:40 |
| 3 | Republic First Bancorp (FRBK) | 0.81 | 15.07% | 2023-05-08 12:23:08 |
| 4 | Virgin Galactic (SPCE) | 4.10 | 13.43% | 2023-05-08 13:46:56 |
| 5 | Galectin Therapeutics (GALT) | 1.88 | 11.24% | 2023-05-08 15:09:07 |
| 6 | First Citizens BancShares (FCNCA) | 1092.43 | 8.84% | 2023-05-08 14:56:59 |
| 7 | Spectra Energy (SE) | 84.84 | 8.2% | 2023-05-08 13:44:44 |
| 8 | Geo Group (GEO) | 8.18 | 7.71% | 2023-05-08 13:40:43 |
| 9 | Fastly (FSLY) | 12.68 | 7.64% | 2023-05-08 13:47:08 |
| 10 | CrowdStrike Holdings (CRWD) | 131.61 | 7.48% | 2023-05-08 13:36:38 |
The three biggest losers today are Catalent, Aspen Group, and Tyson Foods.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Catalent (CTLT) | 35.72 | -25.19% | 2023-05-08 14:50:21 |
| 2 | Aspen Group (ASPU) | 0.07 | -17.65% | 2023-05-08 13:29:56 |
| 3 | Tyson Foods (TSN) | 51.15 | -15.73% | 2023-05-08 14:54:03 |
| 4 | Marathon (MARA) | 9.29 | -11.44% | 2023-05-08 14:58:32 |
| 5 | MicroStrategy (MSTR) | 294.68 | -9.81% | 2023-05-08 14:58:52 |
| 6 | Riot Blockchain (RIOT) | 10.44 | -9.58% | 2023-05-08 14:47:37 |
| 7 | Fate Therapeutics (FATE) | 5.68 | -7.94% | 2023-05-08 07:23:08 |
| 8 | Upland Software (UPLD) | 3.47 | -5.84% | 2023-05-08 14:45:24 |
| 9 | Globalstar (GSAT) | 0.94 | -5.7% | 2023-05-08 13:47:26 |
| 10 | Xenetic Biosciences (XBIO) | 0.41 | -5.38% | 2023-05-08 14:18:12 |
Winners today
1. FuboTV (FUBO) – 25.85%
fuboTV Inc. operates a live TV streaming platform for live sports, news, and entertainment content in the United States and internationally. Its fuboTV platform allows customers to access content through streaming devices, as well as on SmartTVs, computers, mobile phones, and tablets. The company is headquartered in New York, New York.
NYSE ended the session with FuboTV jumping 25.85% to $1.85 on Monday while NYSE rose 0.07% to $15,391.27.
Earnings Per Share
As for profitability, FuboTV has a trailing twelve months EPS of $-2.95.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -99.5%.
Volatility
FuboTV’s last week, last month’s, and last quarter’s current intraday variation average was 6.64%, 2.14%, and 6.10%.
FuboTV’s highest amplitude of average volatility was 14.19% (last week), 6.73% (last month), and 6.10% (last quarter).
Revenue Growth
Year-on-year quarterly revenue growth grew by 43.5%, now sitting on 919.78M for the twelve trailing months.
Moving Average
FuboTV’s worth is way below its 50-day moving average of $2.12 and way below its 200-day moving average of $3.00.
More news about FuboTV.
2. Zscaler (ZS) – 20.11%
Zscaler, Inc. operates as a cloud security company worldwide. It offers Zscaler Internet Access solution that provides users, workloads, IoT, and OT devices secure access to externally managed applications, including software-as-a-service (SaaS) applications and internet destinations; and Zscaler Private Access solution, which is designed to provide access to managed applications hosted internally in data centers, and private or public clouds. The company also provides Zscaler Digital Experience that measures end-to-end user experience across business applications, as well as provides an easy to understand digital experience score for each user, application, and location within an enterprise. In addition, it offers Posture Control solutions comprising Cloud Security Posture Management that identifies and remediates application misconfigurations in SaaS, infrastructure as a service, and PaaS to reduce risk and ensure compliance with industry and organizational benchmarks; Cloud Infrastructure Entitlement Management that detects and remediates excessive or unused cloud permissions and enforces least privileged access without disrupting productivity; Infrastructure as Code (IaC), which analyzes IaC templates to identify misconfigurations and other security issues prior to deployment to cloud infrastructure; and Vulnerability Scanning and Data Loss Prevention solutions. The company's platform modules include Zscaler Central Authority, Zscaler Enforcement Node, and Zscaler Log Servers. It serves customers in airlines and transportation, conglomerates, consumer goods and retail, financial services, healthcare, manufacturing, media and communications, public sector and education, technology, and telecommunications services industries. The company was formerly known as SafeChannel, Inc., and changed its name to Zscaler, Inc. in August 2008. Zscaler, Inc. was incorporated in 2007 and is headquartered in San Jose, California.
NASDAQ ended the session with Zscaler rising 20.11% to $107.45 on Monday while NASDAQ jumped 0.18% to $12,256.92.
Zscaler guidance news: ZS stock soars 21% on raised Q3 guidance, cybersecurity shares spikeWhile Zscaler was trading around $105, Henderson said that Zscaler would double its operating margin and grow revenues at a 30%+ long-term rate. , Well, I cannot say I see $210 over the next twelve months, but Zscaler stock sure looks like its primed for a further rally.
Earnings Per Share
As for profitability, Zscaler has a trailing twelve months EPS of $-2.33.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -60.8%.
Volume
Today’s last reported volume for Zscaler is 13156900 which is 382% above its average volume of 2729640.
Yearly Top and Bottom Value
Zscaler’s stock is valued at $107.45 at 17:32 EST, way under its 52-week high of $231.36 and higher than its 52-week low of $98.71.
More news about Zscaler.
3. Republic First Bancorp (FRBK) – 15.07%
Republic First Bancorp, Inc. operates as the holding company for Republic First Bank that provides a range of credit and depository banking products and services to individuals and businesses. It accepts consumer and commercial deposit, checking, interest-bearing demand, money market, savings, sweep, and individual retirement accounts, as well as certificates of deposit. The company also offers secured and unsecured commercial, real estate, construction and land development, automobile, and home improvement loans; mortgages, home equity and overdraft lines of credit, and other products; and lockbox services. As of April 5, 2022, it operated 34 offices located in Atlantic, Burlington, Camden, and Gloucester counties in New Jersey; Bucks, Delaware, Montgomery, and Philadelphia counties in Pennsylvania; and New York County in New York. Republic First Bancorp, Inc. was founded in 1987 and is based in Philadelphia, Pennsylvania.
NASDAQ ended the session with Republic First Bancorp jumping 15.07% to $0.81 on Monday while NASDAQ jumped 0.18% to $12,256.92.
Earnings Per Share
As for profitability, Republic First Bancorp has a trailing twelve months EPS of $0.2.
PE Ratio
Republic First Bancorp has a trailing twelve months price to earnings ratio of 4.03. Meaning, the purchaser of the share is investing $4.03 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.96%.
Moving Average
Republic First Bancorp’s value is way below its 50-day moving average of $1.40 and way below its 200-day moving average of $2.42.
Sales Growth
Republic First Bancorp’s sales growth is negative 6% for the current quarter and negative 22.8% for the next.
Revenue Growth
Year-on-year quarterly revenue growth declined by 37.7%, now sitting on 164.07M for the twelve trailing months.
More news about Republic First Bancorp.
4. Virgin Galactic (SPCE) – 13.43%
Virgin Galactic Holdings, Inc. focuses on the development, manufacture, and operation of spaceships and related technologies for conducting commercial human spaceflight and flying commercial research and development payloads into space. It is also involved in the ground and flight testing, and post-flight maintenance of its spaceflight system vehicles. The company serves private individuals, researchers, and government agencies. Virgin Galactic Holdings, Inc. was founded in 2017 is headquartered in Las Cruces, New Mexico.
NYSE ended the session with Virgin Galactic jumping 13.43% to $4.10 on Monday, after four consecutive sessions in a row of gains. NYSE rose 0.07% to $15,391.27, following the last session’s upward trend on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, Virgin Galactic has a trailing twelve months EPS of $-1.98.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -54.33%.
Yearly Top and Bottom Value
Virgin Galactic’s stock is valued at $4.10 at 17:32 EST, way below its 52-week high of $11.25 and way above its 52-week low of $3.24.
More news about Virgin Galactic.
5. Galectin Therapeutics (GALT) – 11.24%
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatitis cirrhosis, as well as for the treatment of cancer. It also engages in developing GM-CT-01, which is in pre-clinical development stage for the treatment of cardiac and vascular fibrosis, as well as focuses on developing belapectin for the treatment of psoriasis, and lung and kidney fibrosis. The company, through its Galectin Sciences, LLC, which is a collaborative joint venture co-owned by SBH Sciences, Inc., to research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
NASDAQ ended the session with Galectin Therapeutics jumping 11.24% to $1.88 on Monday while NASDAQ rose 0.18% to $12,256.92.
Earnings Per Share
As for profitability, Galectin Therapeutics has a trailing twelve months EPS of $-0.67.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Galectin Therapeutics’s EBITDA is -8.08.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 23.5% and a negative 31.2%, respectively.
Yearly Top and Bottom Value
Galectin Therapeutics’s stock is valued at $1.88 at 17:32 EST, way below its 52-week high of $2.57 and way above its 52-week low of $1.02.
More news about Galectin Therapeutics.
6. First Citizens BancShares (FCNCA) – 8.84%
First Citizens BancShares, Inc. operates as the holding company for First-Citizens Bank & Trust Company that provides retail and commercial banking services to individuals, businesses, and professionals. The company's deposit products include checking, savings, money market, and time deposit accounts. Its loan product portfolio comprises commercial construction and mortgage; and commercial and industrial leases, as well as small business administration paycheck protection program loans. In addition, the company offers consumer loans, such as residential and revolving mortgage, construction and land development, consumer auto, and other consumer loans. Further, it provides wealth management services, including annuities, discount brokerage services, and third-party mutual funds, as well as investment management and advisory services. The company provides its products and services through its branch network. First Citizens BancShares, Inc. was founded in 1898 and is headquartered in Raleigh, North Carolina.
NASDAQ ended the session with First Citizens BancShares rising 8.84% to $1,092.43 on Monday, following the last session’s upward trend. NASDAQ rose 0.18% to $12,256.92, following the last session’s upward trend on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, First Citizens BancShares has a trailing twelve months EPS of $67.35.
PE Ratio
First Citizens BancShares has a trailing twelve months price to earnings ratio of 16.22. Meaning, the purchaser of the share is investing $16.22 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.25%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 29, 2023, the estimated forward annual dividend rate is 3 and the estimated forward annual dividend yield is 0.3%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 142%, now sitting on 4B for the twelve trailing months.
Volume
Today’s last reported volume for First Citizens BancShares is 246873 which is 12.02% above its average volume of 220378.
More news about First Citizens BancShares.
7. Spectra Energy (SE) – 8.2%
Sea Limited, together with its subsidiaries, engages in the digital entertainment, e-commerce, and digital financial service businesses in Southeast Asia, Latin America, rest of Asia, and internationally. It offers Garena digital entertainment platform for users to access mobile and PC online games, as well as eSports operations. The company also operates Shopee e-commerce platform, a mobile-centric marketplace that provides integrated payment and logistics infrastructure and seller services. In addition, it offers SeaMoney digital financial services to individuals and businesses, including offline and online mobile wallet, and payment processing services, as well as other offerings across credit, insurtech, and digital bank services under the ShopeePay, SPayLater, SeaBank, SeaInsure, and other digital financial services brands; and payment processing services for Shopee. The company was formerly known as Garena Interactive Holding Limited and changed its name to Sea Limited in April 2017. Sea Limited was incorporated in 2009 and is headquartered in Singapore.
NYSE ended the session with Spectra Energy rising 8.2% to $84.84 on Monday while NYSE rose 0.07% to $15,391.27.
Earnings Per Share
As for profitability, Spectra Energy has a trailing twelve months EPS of $-3.12.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -25.05%.
Volume
Today’s last reported volume for Spectra Energy is 4452160 which is 7.05% below its average volume of 4790060.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.1%, now sitting on 12.45B for the twelve trailing months.
Moving Average
Spectra Energy’s worth is above its 50-day moving average of $77.59 and way above its 200-day moving average of $65.27.
More news about Spectra Energy.
8. Geo Group (GEO) – 7.71%
The GEO Group, Inc. (NYSE: GEO) is a leading diversified government service provider, specializing in design, financing, development, and support services for secure facilities, processing centers, and community reentry centers in the United States, Australia, South Africa, and the United Kingdom. GEO's diversified services include enhanced in-custody rehabilitation and post-release support through the award-winning GEO Continuum of Care®, secure transportation, electronic monitoring, community-based programs, and correctional health and mental health care. GEO's worldwide operations include the ownership and/or delivery of support services for 102 facilities totaling approximately 82,000 beds, including idle facilities and projects under development, with a workforce of up to approximately 18,000 employees.
NYSE ended the session with Geo Group jumping 7.71% to $8.18 on Monday, following the last session’s upward trend. NYSE jumped 0.07% to $15,391.27, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, Geo Group has a trailing twelve months EPS of $1.15.
PE Ratio
Geo Group has a trailing twelve months price to earnings ratio of 7.11. Meaning, the purchaser of the share is investing $7.11 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.55%.
Sales Growth
Geo Group’s sales growth for the next quarter is negative 0.7%.
Yearly Top and Bottom Value
Geo Group’s stock is valued at $8.18 at 17:32 EST, way below its 52-week high of $12.44 and way above its 52-week low of $5.75.
More news about Geo Group.
9. Fastly (FSLY) – 7.64%
Fastly, Inc. operates an edge cloud platform for processing, serving, and securing its customer's applications in the United States, the Asia Pacific, Europe, and internationally. The edge cloud is a category of Infrastructure as a Service that enables developers to build, secure, and deliver digital experiences at the edge of the internet. It is a programmable platform designed for web and application delivery. The company offers Compute@Edge; network services to speed up and optimize the delivery of web and application traffic; device detection and geolocation; content delivery network, such as dynamic site acceleration, origin shield, instant purge, surrogate keys, programmatic control, content compression, reliability, and modern protocols and performance services; and streaming solutions and services, including live streaming and media shield. It also provides edge security solutions, such as DDoS protection, next-gen WAF, bot protection, API and ATO protection, advanced rate limiting, and compliance services; transport layer security (TLS) and platform TLS; and origin connect. In addition, the company offers edge applications, such as load balancers and image optimizers; video on demand; and edge delivery services. It serves customers operating in digital publishing, media and entertainment, technology, online retail and education, SaaS, travel and hospitality, and financial services industries. The company was formerly known as SkyCache, Inc. and changed its name to Fastly, Inc. in May 2012. Fastly, Inc. was incorporated in 2011 and is headquartered in San Francisco, California.
NYSE ended the session with Fastly rising 7.64% to $12.68 on Monday while NYSE jumped 0.07% to $15,391.27.
Earnings Per Share
As for profitability, Fastly has a trailing twelve months EPS of $-1.3.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -20.34%.
Volume
Today’s last reported volume for Fastly is 3140740 which is 36.36% below its average volume of 4935480.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 33.3% and 60.9%, respectively.
More news about Fastly.
10. CrowdStrike Holdings (CRWD) – 7.48%
CrowdStrike Holdings, Inc. provides cloud-delivered protection across endpoints and cloud workloads, identity, and data. It offers corporate workload security, security and vulnerability management, managed security services, IT operations management, threat intelligence services, identity protection, and log management. The company primarily sells subscriptions to its Falcon platform and cloud modules through its direct sales team that leverages its network of channel partners. It serves customers worldwide. The company was incorporated in 2011 and is headquartered in Austin, Texas.
NASDAQ ended the session with CrowdStrike Holdings jumping 7.48% to $131.61 on Monday, after three sequential sessions in a row of gains. NASDAQ jumped 0.18% to $12,256.92, following the last session’s upward trend on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, CrowdStrike Holdings has a trailing twelve months EPS of $-0.83.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -14.44%.
Sales Growth
CrowdStrike Holdings’s sales growth is 38.9% for the current quarter and 34.3% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 47.9%, now sitting on 2.24B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CrowdStrike Holdings’s stock is considered to be oversold (<=20).
More news about CrowdStrike Holdings.
Losers Today
1. Catalent (CTLT) – -25.19%
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactures cell therapy and viral based gene therapy; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, vials, and cartridges; and analytical development and testing services. The Oral and Specialty Delivery segment offers formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. This segment also offers oral delivery solutions platform comprising pre-clinical screening, formulation, analytical development, and current good manufacturing practices services. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics, and cell and gene therapies in clinical trials. The company also offers FlexDirect direct-to-patient and FastChain demand-led clinical supply services. It serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. The company was incorporated in 2007 and is headquartered in Somerset, New Jersey.
NYSE ended the session with Catalent sliding 25.19% to $35.72 on Monday, after two sequential sessions in a row of losses. NYSE jumped 0.07% to $15,391.27, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, Catalent has a trailing twelve months EPS of $2.23.
PE Ratio
Catalent has a trailing twelve months price to earnings ratio of 16.02. Meaning, the purchaser of the share is investing $16.02 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.73%.
More news about Catalent.
2. Aspen Group (ASPU) – -17.65%
Aspen Group, Inc., an education technology company, provides online higher education services in the United States. The company offers baccalaureate, master's, and doctoral degree programs in nursing and health sciences, business and technology, arts and sciences, and education fields through Aspen University and United States University. As of April 30, 2022, it had 13,334 degree-seeking students enrolled. Aspen Group, Inc. was founded in 1987 and is based in New York, New York.
NASDAQ ended the session with Aspen Group sliding 17.65% to $0.07 on Monday, following the last session’s upward trend. NASDAQ rose 0.18% to $12,256.92, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, Aspen Group has a trailing twelve months EPS of $-0.51.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -28.28%.
Sales Growth
Aspen Group’s sales growth is negative 24% for the current quarter and negative 29.3% for the next.
Revenue Growth
Year-on-year quarterly revenue growth declined by 9.9%, now sitting on 74.29M for the twelve trailing months.
Yearly Top and Bottom Value
Aspen Group’s stock is valued at $0.07 at 17:32 EST, way under its 52-week high of $1.34 and way higher than its 52-week low of $0.03.
Moving Average
Aspen Group’s worth is way under its 50-day moving average of $0.12 and way under its 200-day moving average of $0.38.
More news about Aspen Group.
3. Tyson Foods (TSN) – -15.73%
Tyson Foods, Inc., together with its subsidiaries, operates as a food company worldwide. It operates through four segments: Beef, Pork, Chicken, and Prepared Foods. The company processes live fed cattle and live market hogs; fabricates dressed beef and pork carcasses into primal and sub-primal meat cuts, as well as case ready beef and pork, and fully cooked meats; raises and processes chickens into fresh, frozen, and value-added chicken products, including breaded chicken strips, nuggets, patties, and other ready-to-fix or fully cooked chicken parts; and supplies poultry breeding stock. It also manufactures and markets frozen and refrigerated food products, including ready-to-eat sandwiches, flame-grilled hamburgers, Philly steaks, pepperoni, bacon, breakfast sausage, turkey, lunchmeat, hot dogs, flour and corn tortilla products, appetizers, snacks, prepared meals, ethnic foods, side dishes, meat dishes, breadsticks, and processed meats under the Jimmy Dean, Hillshire Farm, Ball Park, Wright, State Fair, Aidells, and Gallo Salame brands. In addition, the company offers its products under the Tyson and ibp brands. It sells its products through its sales staff to grocery retailers, grocery wholesalers, meat distributors, warehouse club stores, military commissaries, industrial food processing companies, chain restaurants or their distributors, live markets, international export companies, and domestic distributors who serve restaurants and food service operations, such as plant and school cafeterias, convenience stores, hospitals, and other vendors, as well as through independent brokers and trading companies. The company was founded in 1935 and is headquartered in Springdale, Arkansas.
NYSE ended the session with Tyson Foods falling 15.73% to $51.15 on Monday, after two consecutive sessions in a row of gains. NYSE jumped 0.07% to $15,391.27, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.
: tyson foods swings to a loss, stock fallsLooking ahead, Tyson Foods expects fiscal 2023 revenue of $53 billion to $54 billion, short of the Wall Street…
Earnings Per Share
As for profitability, Tyson Foods has a trailing twelve months EPS of $6.73.
PE Ratio
Tyson Foods has a trailing twelve months price to earnings ratio of 7.6. Meaning, the purchaser of the share is investing $7.6 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.75%.
More news about Tyson Foods.
4. Marathon (MARA) – -11.44%
Marathon Digital Holdings, Inc. operates as a digital asset technology company that mines digital assets with a focus on the blockchain ecosystem and the generation of digital assets in United States. The company was formerly known as Marathon Patent Group, Inc. and changed its name to Marathon Digital Holdings, Inc. in February 2021. Marathon Digital Holdings, Inc. was incorporated in 2010 and is headquartered in Fort Lauderdale, Florida.
NASDAQ ended the session with Marathon falling 11.44% to $9.29 on Monday, after two sequential sessions in a row of gains. NASDAQ rose 0.18% to $12,256.92, following the last session’s upward trend on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, Marathon has a trailing twelve months EPS of $-6.65.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -128.6%.
More news about Marathon.
5. MicroStrategy (MSTR) – -9.81%
MicroStrategy Incorporated provides enterprise analytics software and services in the United States, Canada, Europe, the Middle East, Africa, and internationally. It offers MicroStrategy, an enterprise analytics software platform that enables users to create visualizations, customize apps, and embed analytics directly into workflows; and MicroStrategy Cloud Environment, a managed software-as-a-service solution, which offers always-on threat monitoring and enables rapid analytics development and deployment to deliver security and data privacy requirements. The company also provides MicroStrategy Support that helps customers to achieve their system availability and uptime goals, and to improve the overall experience through highly responsive troubleshooting and proactive technical product support. In addition, it offers MicroStrategy Consulting, which offers customers with architecture and implementation services to help them quickly realize results, as well as helps to achieve returns on investment derived from understanding of data; and MicroStrategy Education that provides free and paid learning options, as well as holds and acquires bitcoin. The company offers its services through enterprise sales force and channel partners. It serves companies from a range of industries, including banking, technology, consulting, manufacturing, insurance, healthcare, and telecommunications, as well as the public sector. The company was incorporated in 1989 and is headquartered in Tysons Corner, Virginia.
NASDAQ ended the session with MicroStrategy dropping 9.81% to $294.68 on Monday while NASDAQ jumped 0.18% to $12,256.92.
Earnings Per Share
As for profitability, MicroStrategy has a trailing twelve months EPS of $-92.85.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -134.41%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 99.4% and 78.2%, respectively.
More news about MicroStrategy.
6. Riot Blockchain (RIOT) – -9.58%
Riot Platforms, Inc., together with its subsidiaries, operates as a bitcoin mining company in North America. It operates through Bitcoin Mining, Data Center Hosting, and Engineering segments. The company also provides co-location services for institutional-scale bitcoin mining companies; and critical infrastructure and workforce for institutional-scale miners to deploy and operate their miners. In addition, it engages in the design and manufacturing of power distribution equipment and custom engineered electrical products; electricity distribution product design, manufacture, and installation services primarily focused on large-scale commercial and governmental customers, as well as a range of markets, including data center, power generation, utility, water, industrial, and alternative energy; operation of data centers; and maintenance/management of computing capacity. The company was formerly known as Riot Blockchain, Inc. Riot Platforms, Inc. was incorporated in 1998 and is based in Castle Rock, Colorado.
NASDAQ ended the session with Riot Blockchain dropping 9.58% to $10.44 on Monday while NASDAQ rose 0.18% to $12,256.92.
Earnings Per Share
As for profitability, Riot Blockchain has a trailing twelve months EPS of $-3.58.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.77%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Riot Blockchain’s EBITDA is -11.83.
Moving Average
Riot Blockchain’s worth is way above its 50-day moving average of $9.21 and way higher than its 200-day moving average of $6.90.
More news about Riot Blockchain.
7. Fate Therapeutics (FATE) – -7.94%
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat multiple myeloma; FT819 to treat hematologic malignancies and solid tumors; FT536 to treat solid tumors; and FT500 for the treatment of advanced solid tumors. The company has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of two off-the-shelf iPSC-derived CAR T-cell product candidates; strategic research collaboration and license agreement with Juno Therapeutics, Inc. to screen for and identify small molecule modulators that enhance the therapeutic properties of genetically-engineered T-cell immunotherapies; and a collaboration and option agreement with Janssen Biotech, Inc. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
NASDAQ ended the session with Fate Therapeutics sliding 7.94% to $5.68 on Monday, after two sequential sessions in a row of losses. NASDAQ rose 0.18% to $12,256.92, following the last session’s upward trend on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, Fate Therapeutics has a trailing twelve months EPS of $-2.79.
Moving Average
Fate Therapeutics’s value is under its 50-day moving average of $5.77 and way under its 200-day moving average of $15.79.
Yearly Top and Bottom Value
Fate Therapeutics’s stock is valued at $5.68 at 17:32 EST, way below its 52-week high of $37.13 and way above its 52-week low of $4.02.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 24.1% and 36%, respectively.
Sales Growth
Fate Therapeutics’s sales growth is negative 65.8% for the current quarter and negative 90.7% for the next.
More news about Fate Therapeutics.
8. Upland Software (UPLD) – -5.84%
Upland Software, Inc. provides cloud-based enterprise work management software in the United States, the United Kingdom, Canada, and internationally. It offers a family of software applications under the Upland brand in the areas of marketing, sales, contact center, project management, information technology, business operations, and human resources and legal. The company also provides professional services, such as implementation, data extraction, integration and configuration, and training services, as well as customer support services. It serves large global corporations, various government agencies, and small and medium-sized businesses, as well as financial, consulting, technology, manufacturing, media, telecommunication, political, healthcare, life sciences, and retail and hospitality sectors. The company was formerly known as Silverback Enterprise Group, Inc. and changed its name to Upland Software, Inc. in November 2013. Upland Software, Inc. was incorporated in 2010 and is headquartered in Austin, Texas.
NASDAQ ended the session with Upland Software sliding 5.84% to $3.47 on Monday while NASDAQ jumped 0.18% to $12,256.92.
Earnings Per Share
As for profitability, Upland Software has a trailing twelve months EPS of $-2.27.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Upland Software’s EBITDA is -370.62.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 56.4% and a negative 52%, respectively.
Sales Growth
Upland Software’s sales growth is negative 7% for the present quarter and negative 5.4% for the next.
More news about Upland Software.
9. Globalstar (GSAT) – -5.7%
Globalstar, Inc. provides mobile satellite services worldwide. The company offers duplex two-way voice and data products, including mobile voice and data satellite communications services and equipment for remote business continuity, recreational usage, safety, emergency preparedness and response, and other applications. It also provides one-way or two-way communications and data transmissions using mobile devices, including the SPOT family of products, such as SPOT X, SPOT Gen4, and SPOT Trace that transmit messages and the location of the device; commercial Internet of Things transmission products to track cargo containers and rail cars, as well as to monitor utility meters, and oil and gas assets; small satellite transmitter modules, such as the STX-3, ST-150 and ST100, and chips that enable an integrator's products to access company's network; and engineering and other communication services using MSS and terrestrial spectrum licenses, as well as undertakes installation of gateways and antennas. The company distributes its products through retailers, sales force, and e-commerce website. Globalstar, Inc. serves recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, construction, utilities, and transportation, as well as natural resources, mining, and forestry markets. The company was founded in 1993 and is headquartered in Covington, Louisiana.
NYSE ended the session with Globalstar falling 5.7% to $0.94 on Monday while NYSE rose 0.07% to $15,391.27.
Earnings Per Share
As for profitability, Globalstar has a trailing twelve months EPS of $-0.15.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Globalstar’s stock is considered to be oversold (<=20).
Volatility
Globalstar’s last week, last month’s, and last quarter’s current intraday variation average was a positive 2.76%, a negative 0.40%, and a positive 3.50%.
Globalstar’s highest amplitude of average volatility was 4.39% (last week), 2.73% (last month), and 3.50% (last quarter).
Volume
Today’s last reported volume for Globalstar is 4971330 which is 20.98% above its average volume of 4109180.
More news about Globalstar.
10. Xenetic Biosciences (XBIO) – -5.38%
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition, the company leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, and PJSC Pharmsynthez. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.
NASDAQ ended the session with Xenetic Biosciences falling 5.38% to $0.41 on Monday while NASDAQ rose 0.18% to $12,256.92.
Earnings Per Share
As for profitability, Xenetic Biosciences has a trailing twelve months EPS of $-0.47.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.9%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 8.3% and 42.1%, respectively.
Volatility
Xenetic Biosciences’s last week, last month’s, and last quarter’s current intraday variation average was 0.18%, 0.17%, and 4.41%.
Xenetic Biosciences’s highest amplitude of average volatility was 5.22% (last week), 4.21% (last month), and 4.41% (last quarter).
Earnings Before Interest, Taxes, Depreciation, and Amortization
Xenetic Biosciences’s EBITDA is 6.09.
Volume
Today’s last reported volume for Xenetic Biosciences is 28172 which is 16.38% below its average volume of 33691.
More news about Xenetic Biosciences.
Stay up to date with our winners and losers daily report
